Cite
Boucher A, Ezzat S, Hotte S, et al. Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer. Oral Oncol. 2021;121:105477doi: 10.1016/j.oraloncology.2021.105477.
Boucher, A., Ezzat, S., Hotte, S., Rachinsky, I., Rajaraman, M., Ruether, D., Wiseman, S. M., Brierley, J., Ho, C., Krzyzanowska, M., Lamond, N., Massicotte, M. H., Joseph, S., Herscovitch, K., Sikora, L., & Winquist, E. (2021). Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer. Oral oncology, 121105477. https://doi.org/10.1016/j.oraloncology.2021.105477
Boucher, Andrée, et al. "Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer." Oral oncology vol. 121 (2021): 105477. doi: https://doi.org/10.1016/j.oraloncology.2021.105477
Boucher A, Ezzat S, Hotte S, Rachinsky I, Rajaraman M, Ruether D, Wiseman SM, Brierley J, Ho C, Krzyzanowska M, Lamond N, Massicotte MH, Joseph S, Herscovitch K, Sikora L, Winquist E. Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer. Oral Oncol. 2021 Oct;121:105477. doi: 10.1016/j.oraloncology.2021.105477. Epub 2021 Aug 10. PMID: 34388408.
Copy
Download .nbib